
AstraZeneca antibody cocktail succeeds in late-stage study to treat Covid-19
AstraZeneca’s experimental Covid-19 drug has helped cut the risk of severe disease or death in a late-stage study, the British drugmaker said on Monday, a boost to its efforts ...